Unknown

Dataset Information

0

A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guerin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)


ABSTRACT:

SUBMITTER: Steinberg G 

PROVIDER: S-EPMC4288751 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC11902301 | biostudies-literature
| S-EPMC7025668 | biostudies-literature
| S-EPMC1891101 | biostudies-literature
| S-EPMC7921379 | biostudies-literature